@article{f3bb5dcde97f496f84eaa5a12c792b92,
title = "Treatment of hospital-acquired pneumonia - Authors' Reply",
author = "Kett, {Daniel H.} and Quartin, {Andrew A.} and Mangino, {Julie E.} and Zervos, {Marcus J.} and Ramirez, {Julio A.}",
note = "Funding Information: DHK has received research support from Pfizer, and has been a consultant and member of the speakers' bureau of Pfizer, Astellas, Cubist, and GlaxoSmithKline. AAQ declares that he has no conflicts of interest to disclose. JEM has served on an advisory board for Medline. MJZ has received research support from Astellas, Cubist, and Johnson and Johnson, and is on the speakers' bureaux of Astellas and Cubist. JAR has received research support from, and is a consultant for, Pfizer, and has received lecture honoraria from Pfizer, Merck, and Wyeth. Copyright: Copyright 2011 Elsevier B.V., All rights reserved.",
year = "2011",
month = oct,
doi = "10.1016/S1473-3099(11)70265-1",
language = "English (US)",
volume = "11",
pages = "731--732",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "10",
}
